- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07946185
Pediatric OCD Talus RCT Feasibility
Feasibility of a Randomized Trial Comparing Viable Cartilage Allograft and Arthroscopic Drilling for Pediatric Talar Osteochondritis Dissecans
Osteochondritis dissecans (OCD) of the talus is a condition affecting the bone and cartilage of the ankle joint. It can cause pain, swelling, stiffness, and difficulty participating in sports and daily activities. Children and adolescents with persistent symptoms or unstable lesions may require surgery when nonsurgical treatments are unsuccessful.
Two surgical approaches used to treat this condition are arthroscopic drilling and chondroplasty, which aim to stimulate healing of the affected bone and cartilage, and viable cartilage allograft implantation, which uses donated cartilage material to repair the damaged area. There is limited evidence comparing these treatments in children and adolescents, and it is not known whether one approach provides better outcomes.
This pilot randomized controlled trial aims to assess the feasibility of conducting a larger study comparing these two surgical treatments in pediatric patients with talar OCD. Approximately 20 participants requiring surgery will be recruited at the Children's Hospital of Eastern Ontario (CHEO) and randomly assigned to receive either viable cartilage allograft implantation (CartiMax®) or arthroscopic drilling and chondroplasty.
The primary objective is to assess the feasibility of recruitment, acceptance of randomization, participant retention, completion of imaging and questionnaires, and adherence to the study procedures. Secondary objectives include exploring differences in ankle pain, function, healing on magnetic resonance imaging (MRI), complications, and the need for additional surgery.
Participants will undergo postoperative rehabilitation according to standard clinical care and will be followed for up to 24 months after surgery.
The findings will help determine whether a larger multicentre randomized trial is feasible and provide preliminary information about healing and recovery following each surgical treatment. This pilot study is not designed to determine which treatment is more effective.
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
Osteochondritis dissecans (OCD) of the talus is a condition that affects the bone and cartilage in the ankle joint. It can cause pain, swelling, stiffness, and difficulty participating in sports and everyday activities. Some children and adolescents with this condition require surgery when treatments such as rest, activity restrictions, and immobilization have not improved their symptoms.
Two surgical approaches are available to treat this condition. One involves drilling small holes into the affected bone and smoothing damaged cartilage to encourage healing. The other involves placing donated cartilage material into the damaged area to support cartilage repair. It is not yet known whether one approach leads to better healing and recovery in children and adolescents.
The main purpose of this pilot study is to determine whether it is feasible to conduct a larger study comparing these two surgical treatments. Researchers will assess whether enough patients can be recruited, whether families are willing to accept random assignment to either treatment, and whether participants can complete the required follow-up visits, imaging, and questionnaires.
The study will include approximately 20 children and adolescents who require surgery for osteochondritis dissecans of the talus at the Children's Hospital of Eastern Ontario (CHEO) in Ottawa, Canada. Participants will be randomly assigned, like flipping a coin, to receive one of two surgical treatments:
- **Viable cartilage allograft:** Surgery to prepare the damaged area and place donated cartilage material (CartiMax®) into the defect.
- **Arthroscopic drilling and chondroplasty:** Surgery using a small camera and instruments to smooth damaged cartilage and drill into the underlying bone to encourage healing.
All participants will receive the same standard postoperative rehabilitation approach. Follow-up assessments will take place approximately 2 weeks, 6 weeks, 3 months, 6 months, 12 months, and 24 months after surgery. Researchers will assess ankle pain, function, healing on imaging, return to sports, complications, and whether additional surgery is needed.
The researchers expect this pilot study to help determine whether a larger randomized trial can be successfully conducted. The study will also provide early information about healing and recovery after each treatment. Because this is a small pilot study, it is not designed to determine which surgical treatment is better.
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Holly Livock Research Manager, MSc.
- Telefonnummer: 4120 6137377600
- E-post: hlivock@cheo.on.ca
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Patients aged ≤ 5 years and ≥ 18 years
- Patients seen at the CHEO Orthopaedic Sports Medicine Clinic with symptomatic talar OCD requiring surgery
- Patients that have an unstable lesion on MRI
- Must be able to complete patient-reported outcome measures in English or French
- Are willing to be randomized between the two unblinded surgical approaches.
- Participants must have had failure of non-operative treatment including rest, activity restriction, and six weeks of immobilization.
Exclusion Criteria:
- Unwillingness to attend follow-up appointments or complete research activities.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Viable Cartilage Allograft (CartiMax)
Participants undergo arthroscopic lesion preparation followed by implantation of CartiMax viable cartilage allograft into the damaged area of the talus. Standard postoperative rehabilitation is provided. |
Participants undergo arthroscopic preparation of the talar osteochondral lesion followed by implantation of CartiMax viable cartilage allograft, consisting of viable cartilage fibers and cartilage allograft matrix. The graft is placed into the cartilage defect to support repair. Participants follow the standard postoperative rehabilitation protocol. |
|
Aktiv komparator: Arthroscopic Drilling and Chondroplasty
Participants undergo arthroscopic drilling and chondroplasty to remove or smooth unstable cartilage and stimulate healing of the underlying bone. Standard postoperative rehabilitation is provided. |
Participants undergo arthroscopic drilling and chondroplasty of the talar osteochondral lesion. Unstable cartilage is removed or smoothed, and small channels are drilled into the affected bone to stimulate healing. Participants follow the standard postoperative rehabilitation protocol. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Recruitment Rate
Tidsramme: 24 months
|
Number of participants enrolled per year during the recruitment period. Recruitment feasibility will be assessed against a target of at least 10 participants enrolled per year. |
24 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Questionnaire Completion Rate at 6 Months
Tidsramme: 6 months after surgery
|
Proportion of randomized participants who complete the required 6-month postoperative pain and ankle function assessments, including the Visual Analogue Scale (VAS) and American Orthopaedic Foot and Ankle Society (AOFAS) ankle-hindfoot score. The target questionnaire completion rate is at least 80%. |
6 months after surgery
|
|
MRI Completion Rate at 6 Months
Tidsramme: 6 months after surgery
|
Proportion of randomized participants who complete the scheduled 6-month postoperative magnetic resonance imaging (MRI) assessment. The target MRI completion rate is at least 80%. |
6 months after surgery
|
|
Participant Retention Rate at 6 Months
Tidsramme: 24 months
|
Proportion of randomized participants who remain in the study and complete the 6-month postoperative follow-up assessment. The target retention rate is at least 70%. |
24 months
|
|
Randomization Acceptance Rate
Tidsramme: 24 months
|
Proportion of eligible patients approached for participation who consent to random assignment to either surgical treatment. The target randomization acceptance rate is at least 80%. |
24 months
|
|
Adherence to Randomized Treatment Allocation
Tidsramme: At the time of surgery (assessed up to 1 hour)
|
Proportion of randomized participants who undergo their assigned surgical intervention, either viable cartilage allograft implantation or arthroscopic drilling and chondroplasty. Crossovers and deviations from assigned treatment will be documented. |
At the time of surgery (assessed up to 1 hour)
|
Samarbeidspartnere og etterforskere
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Pallamar M, Eder T, Ganger R, Farr S. Surgical treatment of atraumatic osteochondrosis dissecans of the immature talus-Clinical results and prevalence of radiographic joint degeneration after a median follow-up of 72.5 months. Foot Ankle Surg. 2022 Jul;28(5):557-563. doi: 10.1016/j.fas.2021.05.007. Epub 2021 May 17.
- Jungesblut OD, Berger-Groch J, Hoffmann M, Schroeder M, Krajewski KL, Stuecker R, Rupprecht M. Electromagnetic navigation reduces radiation exposure for retrograde drilling in osteochondrosis dissecans of the talus. BMC Musculoskelet Disord. 2021 Feb 3;22(1):135. doi: 10.1186/s12891-021-04010-4.
- Porta-Alesandria J, Van Bergen CJA, Masquijo JJ. Evaluation and management of osteochondral lesions of the talus in skeletally immature patients. Acta Ortop Mex. 2022 Nov-Dec;36(6):335-339.
- Kim HW, Park KB, Kim CW, Lee KY, Park H. Healing Predictors of Conservative Treatment for Juvenile Osteochondritis Dissecans of the Talus. Clin J Sport Med. 2022 Nov 1;32(6):e635-e643. doi: 10.1097/JSM.0000000000001049. Epub 2022 May 27.
- Li Y, Dong A, Huang Z, Li W, Deng Z. [Advances in the Treatment of Osteochondral Lesions of the Talus]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Mar 20;55(2):273-278. doi: 10.12182/20240360206. Chinese.
- Nguyen JC, Kan JH, Patel VS, Blankenbaker DG, Rubin DA, Shea KG, Nissen CW, Jaramillo D, Ganley TJ. Osteochondritis dissecans in children: location-dependent differences (part II: ankle and elbow). Pediatr Radiol. 2025 Jun;55(7):1386-1402. doi: 10.1007/s00247-025-06259-6. Epub 2025 May 16.
- Jorgensen MS, Shah N, Nadwodny J, Skov R, Pujalte GGA. Osteochondritis Dissecans of the Talar Dome and Navicular Bone in an Adolescent Athlete: A Prolonged Clinical Course. Cureus. 2025 May 5;17(5):e83495. doi: 10.7759/cureus.83495. eCollection 2025 May.
- Mizuo C, Parkman L, Ayazi T, Hu H, Adams A. Osteochondral Lesions of the Talus Treated With Particulated Juvenile Cartilage Allograft in the Active Duty Military Population. Foot Ankle Orthop. 2026 Aug 20;11(3):24730114261471519. doi: 10.1177/24730114261471519. eCollection 2026 Jul.
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- 26/10E
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .